SEARCH

SEARCH BY CITATION

Bibliography

  • 1
    Cochrane AL. Effectiveness and Efficiency. Random Reflections on Health Services. Cambridge: Cambridge University Press, The Nuffield Provincial Hospital Trust, 1989; pp. 4566.
  • 2
    Chalmers I. Evaluating the effects of care during pregnancy and childbirth. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 338.
  • 3
    US Department of Health and Human Services.Caring For Our Future: the Content of Prenatal Care. Washington, DC: Department of Health and Human Services, 1989.
  • 4
    Bergsjø P & Villar J. Scientific basis for the content of routine antenatal care. II. Power to eliminate or alleviate adverse newborn outcome; some special conditions and examinations. Acta Obstetricia et Gynecologica Scandinavica 1997; 76:1525.
  • 5
    Villar J & Bergsjø P. Scientific basis for the content of routine antenatal care. I. Philosophy, recent studies and power to eliminate or alleviate adverse maternal outcomes. Acta Obstetricia et Gynecologica Scandinavica 1997; 76:114.
  • 6
    Oakley A. The origins and development of antenatal care. In: Effectiveness and Satisfaction in Antenatal Care. Editors: Enkin M, Chalmers I. London: Heinemann, 1982.
  • 7
    Enkin M & Chalmers I. Effectiveness and Satisfaction in Antenatal Care. Clinics in Developmental Medicine, Nos. 8l/82. London: Heinemann 1982.
  • 8
    Tew M. Safer Childbirth? A Critical History of Maternity Care. London: Chapman & Hall, 1990.
  • 9
    Weil O & Fernandez H. Is safe motherhood an orphan initiative? Lancet 1999; 354:940943.
  • 10
    Lettenmaier RN, Liskin L, Church CA & Harris TA. Mothers’ lives matter: maternal health in the community. Population Reports Series 1988; 1:132.
  • 11
    Walsh JA, Feifer CN, Measham AR & Gertler PJ. Maternal and perinatal health. In: Disease Control Priorities in Developing Countries. Editors: Jamison DT, Mosley WH. Washington, DC: The World Bank, 1990.
  • 12
    Maine D. Safe Motherhood Programs: Options and Issues. New York: Columbia University, 1991.
  • 13
    Ronsmans C, Vanneste AM, Chakraborty J & Van Ginneken J. Decline in maternal mortality in Matlab, Bangladesh: a cautionary tale. Lancet 1997; 350:18101814.
  • 14
    Renfrew M & Chalmers I. How can prenatal care reduce maternal mortality? WIPHN News 1990; 7:l.
  • 15
    Duby F. How can prenatal care reduce maternal mortality? WIPHN News 1990; 8:9.
  • 16
    Gosh S. How can prenatal care reduce maternal mortality? WIPHN News 1990; 8:910.
  • 17
    Carlson JM. How can prenatal care reduce maternal mortality? WIPHN News 1990; 8:10.
  • 18
    Soetjiningsi H. How can prenatal care reduce maternal mortality? WIPHN News 1990; 8:1011.
  • 19
    Minden M. How can prenatal care reduce maternal mortality? WIPHN News 1990; 8:11.
  • 20
    Rosenfield A. How can prenatal care reduce maternal mortality? WIPHN News 1990; 8:11.
  • 21
    Rooney C. Antenatal Care and Maternal Health: How Effective Is It? A Review of the Evidence. WHO/MSM/92.4. Maternal Health and Safe Motherhood Programme, Division of Family Health. Geneva: World Health Organization, 1992.
  • 22
    Campbell OMR & Graham WJ. Measuring maternal mortality and morbidity: levels and trends. Maternal and Child Epidemiology Unit Publication, No. 2. London: London School of Hygiene and Tropical Medicine, 1990.
  • 23
    Graham WJ. Maternal mortality in Sub-Saharan Africa–differentials, trends and data deficiencies. In: Disease and Mortality in Sub-Saharan Africa. Editors: Feachem RG, Jamison DT. Washington DC: World Bank, Oxford University Press 1991.
  • 24
    World Health Organization. Reduction of Maternal Mortality: A Joint WHO/UNFPA/UNICEF/World Bank Statement. Geneva: World Health Organization, 1999.
  • 25
    Chalmers I, Hetherington J, Elbourne D, Keirse MJNC & Enkin M. Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 4059.
  • 26
    Mohide P & Grant A. Evaluating diagnosis and screening during pregnancy and childbirth. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 6680.
  • 27
    Centre for Evidence Based Medicine, NHS Research and Development. Levels of Evidence and Grades of Recommendations. Levels of Evidence, 2000. http//www.cebm.jr2.ox.ac.uk/
  • 28
    Wilson J & Jungner G. Principles and Practice of Screening for Disease. WHO Public Health Papers. Geneva: World Health Organization, 1968.
  • 29
    Loudon I. Maternal care and maternal mortality in Britain, 1935–1950. In: Death in Childbirth. An International Study of Maternal Care and MaternaI Mortality 1800–1950. Editor: Loudon I. Oxford, Clarendon Press, 1992; pp. 254–273.
  • 30
    Filippi VGA, Graham WJ & Campbell OMR. Utilizing survey data on maternity care in developing countries. Maternal and Child Epidemiology Unit Publication, No. 3. London: London School of Hygiene and Tropical Medicine, 1990.
  • 31
    Boes EGM. Maternal mortality in southern Africa, 1980–1982. Part II. Causes of maternal deaths. South African Medical Journal, 1987; 71:160161.
  • 32
    Boes EGM . Maternal mortality in southern Africa, 1980–1982. Part I. Pregnancy can be lethal. South African Medical Journal, 1987; 71:158160.
  • 33
    Melrose EB. Maternal deaths at King Edward VIII Hospital, Durban: a review of 258 consecutive cases. South African Medical Journal 1984; 65:161165.
  • 34
    Kwast BE, Bekele M, Yoseph S, Gossa A, Mehari L & Frost O. Confidential enquiries into maternal deaths in Addis Ababa, Ethiopia 1981–1983. Journal of Obstetrics and Gynaecology of Eastern and Central Africa, 1989; 8:7582.
  • 35
    Walker GJA, Ashley DEC, McCaw A & Bernard GW. Maternal Mortality in Jamaica. A Confidential Inquiry into All Maternal Deaths in Jamaica 1981–1983. Document FHE/PMM/85.9.10. Geneva: World Health Organization, 1985.
  • 36
    Walker GJA, Ashley DEC, McCaw A & Bernard GW. Maternal mortality in Jamaica. Lancet 1986; 1:486488.
  • 37
    Bhatia JC. Maternal mortality in Anantapur District, India: preliminary findings of a study. Interregional Meeting on Prevention of Maternal Mortality, Geneva, 11–17 November 1985. Document FHE/PMM/85.9.16. Geneva: World Health Organization, 1985.
  • 38
    Bhatia JC. Light on maternal mortality in India. World Health Forum, 1990; 11:188191.
  • 39
    Cook R. The role of confidential enquiries in the reduction of maternal mortality and alternatives to this approach. International Journal of Gynaecology and Obstetrics 1989; 30:4145.
  • 40
    Strachan DP. Antenatal booking and perinatal mortality in Scotland, 1972–1982. International Journal of Epidemiology, 1987; 16:229233.
  • 41
    Thomas P, Golding J & Peters TJ. Delayed antenatal care: does it affect pregnancy outcome? Social Science and Medicine 1991; 32:715723.
  • 42
    World Health Organization. Coverage of Maternity Care. A Tabulation of Available Information. Document WHO/FHE/89.2. Geneva: World Health Organization, 1989.
  • 43
    Briggs ND & Oruamabo RS. Technology-free obstetrics (letter). Lancet 1991; 337:553.
  • 44
    Campbell OMR, Rooney CIF, Filippi VGA & Graham WJ. Technology-free obstetrics (letter). Lancet 1991; 337:554.
  • 45
    Pearce JM & Chamberlain G. Technology-free obstetrics (letter). Lancet 1991; 337:554.
  • 46
    Backett EM, Davies AM & Petros-Barvazian A. The Risk Approach in Health Care, with Special Reference to Maternal and Child Health Including Family Planning. WHO Public Health Papers, No. 76. Geneva: World Health Organization, 1984.
  • 47
    Lilford RJ & Chard T. Problems and pitfalls of risk assessment in antenatal care. British Journal of Obstetrics and Gynaecology 1983; 90:507510.
  • 48
    Keirse MJNC. Interaction between primary and secondary care during pregnancy and childbirth. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 197201.
  • 49
    Hall MH. Identification of low risk and high risk. Baillieres Clinical Obstetrics and Gynaecology 1990; 4:6576.
  • 50
    Chard T, Learmont J, Carroll S, Hudson C, Lloyd DS & Sloan D. Evaluation of a fetal risk scoring system. American Journal of Perinatology 1992; 9:388393.
  • 51
    Shiono PH & Klebanoff MA. A review of risk scoring for preterm birth. Clinics in Perinatology 1993; 20:107125.
  • 52
    Fortney JA & Whitehorne EW. The development of an index of high-risk pregnancy. American Journal of Obstetrics and Gynecology 1982; 143:501508.
  • 53
    Alexander S & Keirse MJNC. Formal risk scoring during pregnancy. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 345365.
  • 54
    Jahn A, Kowalesky M & Kimatta SS. Obstetric care in southern Tanzania: does it reach those in need? Tropical Medicine and International Health 1998; 3:926932.
  • 55
    Bhardwaj N, Badrul Hasan S, Yunus M & Zaheer M. High risk pregnancy and its relation with maternal care receptivity (MCR) – a rural study from India. Journal of the Royal Society of Health 1991; 111:4346.
  • 56
    Harrison K, Rossiter CE & Chong H. Relations between maternal height, fetal birthweight and cephalopelvic disproportion suggest that young Nigerian primigravidae grow during pregnancy. British Journal of Obstetrics and Gynaecology 1985; 92(Suppl. 5):4048.
  • 57
    Hira SK, Bhat GJ, Chikamata DM, Nkowane B, Tembo G & Perine PL et al., Syphilis intervention in pregnancy: Zambian demonstration project. Genitourinary Medicine 1990; 66:159164.
  • 58
    Selwyn BJ. The accuracy of obstetric risk assessment instruments for predicting mortality, low birth weight, and preterm birth. In: New Perspectives on Prenatal Care. Editors: Merkatz IR, Thompson JE, Mullen PD, Goldenberg RL. New York: Elsevier, 1990; pp. 3965.
  • 59
    Bruce I & Winikoff B. Executive summary. Findings from the Seminar on Reassessment of the Concept of Reproductive Risk in Maternity Care and Family Planning Services. New York: The Population Council, 1990.
  • 60
    Région Médicale de Kaolack, Bureau National du Recensement and Family Health International. Pregnancy Care Surveillance in the Kaolack Medical Region, Senegal, September 1984–September 1985. Final Report.1988.
  • 61
    Jelley D & Madeley RJ. Antenatal care in Maputo, Mozambique. Journal of Epidemiology and Public Health 1983; 37:111116.
  • 62
    Voorhoeve AM, Kars C & Van Ginneken JK. Modern and traditional antenatal and delivery care. In: Maternal and Child Health in Rural Kenya. Editors: Van Ginneken JK, Muller AS. London: Croom-Helm, 1984; pp. 309322.
  • 63
    Dujardin B, Clarysse G, Criel B, De Browere V & Wangata N. The strategy of risk approach in antenatal care: evaluation of the referral compliance. Social Science and Medicine 1995; 40:529535.
  • 64
    Martey JO, Djan JO, Twum S, Browne EN & Opoku SA . Referrals for obstetrical complications from Ejisu District, Ghana. West African Journal of Medicine 1998; 17:5863.
  • 65
    Figa-Talamanca I. Maternal mortality and the problem of accessibility to obstetric care; the strategy of maternity waiting homes. Social Science and Medicine 1996; 42:13811390.
  • 66
    Chandramohan D, Cutts F & Chandra R. Effects of a maternity waiting home on adverse maternal outcomes and the validity of antenatal risk screening. International Journal of Gynaecology and Obstetrics 1994; 46:279284.
  • 67
    Chandramohan D, Cutts F & Millard P. The effect of stay in a maternity waiting home on perinatal mortality in rural Zimbabwe. Journal of Tropical Medicine and Hygiene 1995; 98:261267.
  • 68
    Spaans WA, Van Rooosmalen J & Van Wiechen CM. A maternity waiting home experience in Zimbabwe. International Journal of Gynaecology and Obstetrics 1998; 61:179180.
  • 69
    Wilson JB, Collison AH, Richardson D, Kwofie G, Senah KA & Tinkorang EK. The maternity waiting home concept: the Nsawam, Ghana experience. The Accra PMM Team. International Journal of Gynaecology and Obstetrics 1997; 59(Suppl. 2): S165S172.
  • 70
    Tanuwijaya S, Tjokrohusada H, Alisjahbana A & Peeters R. The Use of the ‘Problem-Action-Guidelines’ and ‘Recording-Cards’ for the Identification of At-Risk-Mothers and Infants.1985.
  • 71
    Sauerborn R, Nougtara A, Sorgho G, Bidiga J & Diesfeld HJ. Assessment of MCH services in the district of Solenzo, Burkina Faso. III. Effectiveness of MCH services in detecting and caring for mothers and children at risk. Journal of Tropical Pediatrics 1989; 35(Suppl. 1):1417.
  • 72
    Chng PK, Hall MH & MacGillivray I. An audit of antenatal care: the value of the first antenatal visit. British Medical Journal 1980; 281:11841186.
  • 73
    Guthrie KA, Songane FF, Mackenzie F & Lilford RJ. Audit of medical response to antenatal booking history. British Journal of Obstetrics and Gynaecology 1989; 96:552556.
  • 74
    Shah PM, Shah KP & Belsey MA. The home-based maternal record: a tool for family involvement in health care. IPPF Medical Bulletin 1988; 22:23.
  • 75
    Shah PM. Review of the WHO Collaborative Study on Home-Based Maternal Record: Concepts, Adaptation and Lessons Learnt. Document WHO/MCH/89/12. Geneva: World Health Organization, 1990.
  • 76
    World Health Organization. The Home-Based Mother’s Record. A Guideline for its Adaptation, Use and Evaluation. Document MH/90.12. Geneva: World Health Organization, 1990.
  • 77
    Essen B, Laurell L, Pena R, Ostergren PO & Liljestrand J. Antenatal cards: what should they contain? Journal of Tropical Pediatrics 1994; 40:130132.
  • 78
    Laurell L, Essen B, Pena R, Ostergren PO & Liljestrand J. A study of the use of the Nicaraguan antenatal card. Journal of Tropical Pediatrics 1994; 40:133136.
  • 79
    Hodnett ED. Women carrying their own case-notes during pregnancy. In: Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Editors: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP. London: BMJ Publishing Group, 1995[updated 24 February 1995].
  • 80
    Janowitz B, Wallace S, Araujo G & Araujo L. Referrals by traditional birth attendants in Northeast Brazil. American Journal of Public Health 1985; 75:745748.
  • 81
    Villar J & Khan-Neelofur D. Patterns of routine antenatal care for low risk women (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 82
    Munjanja SP, Lindmark G & Nystrom L. Randomised controlled trial of a reduced-visits programme of antenatal care in Harare, Zimbabwe. Lancet 1996; 348:364369.
  • 83
    Villar J, Bakketeig L, Donner A, Al-Mazrou Y, Ba'Aqeel H & Belzian JM et al., for the WHO Antenatal Care Trial Research Group.The WHO Antenatal Care Randomised Controlled Trial: rationale and study design. Paediatric and Perinatal Epidemiology 1998; 12(Suppl. 2):2758.
  • 84
    World Health Organization. Essential Elements of Obstetric Care at First Referral Level. Geneva: World Health Organization, 1991.
  • 85
    Abou Zahr C & Royston E. Maternal Mortality: A Global Factbook. Geneva: World Health Organization, 1991.
  • 86
    Prendiville WJ, Elbourne D & Mcdonald S. Active versus expectant management in the third stage of labour (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 87
    McDonald S, Prendiville WJ & Elbourne D. Prophylactic syntometrine versus oxytocin for delivery of the placenta (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 88
    Carroli G & Bergel E. Umbilical vein injection for management of retained placenta (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 89
    Lennox CE. An action orientated antenatal card for Papua New Guinea. Papua New Guinea Medical Journal 1981; 24:280285.
  • 90
    Hall MH, Halliwell R & Carr-Hill R. Concomitant and repeated happenings of complications of the third stage of labour. British Journal of Obstetrics and Gynaecology 1985; 92:732738.
  • 91
    Combs CA, Murphy EL & Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstetrics and Gynecology 1991; 77:6976.
  • 92
    Mahomed K & Hytten F. Iron and folate supplementation in pregnancy. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 302317.
  • 93
    Mahomed K. Iron supplementation in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 94
    Mahomed K. Folate supplementation in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 95
    Mahomed K. Iron and folate supplementation in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 96
    Hemminki E & Rimpela U. A randomized comparison of routine vs selective iron supplementation during pregnancy. Journal of the American College of Nutrition 1991; 10:310.
  • 97
    World Health Organization. The Prevalence of Nutritional Anaemia in Women: A Tabulation of Available Information. Document WHO/MCH/MSM/92.2. Geneva: World Health Organization, 1992.
  • 98
    Hughes A. Anaemia in Pregnancy. A Background Paper for Discussion. Geneva: World Health Organization, 1990.
  • 99
    Tuck S & White JM. Sickle cell disease. In: Progress in Obstetrics and Gynaecology, Vol. 1. Editor: Studd J. Edinburgh: Churchill Livingstone, 1981.
  • 100
    Garner P & Gülmezoglu AM. Prevention versus treatment for malaria in pregnant women (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 101
    Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN & Peshu N et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo controlled trial. Lancet 1999; 353:632636.
  • 102
    Gjorup T, Bugge PM, Hendriksen C & Jense AM. A critical evaluation of the clinical diagnosis of anemia. American Journal of Epidemiology 1986; 124:657665.
  • 103
    Wurapa FK, Bulsara MP & Boatin BA. Evaluation of conjunctival pallor in the diagnosis of anaemia. Journal of Tropical Medicine and Hygiene 1986; 89:3336.
  • 104
    Gujral S, Abbi R, Anderson MA, Christian P & Gopaldas T. Agreement between haemoglobin estimation and anaemia recognition card in assessment of anaemia in pregnant women. European Journal of Clinical Nutrition 1989; 43:473475.
  • 105
    Sanchez Carrillo CI. Bias due to conjunctiva hue and the clinical assessment of anaemia. Journal of Clinical Epidemiology 1989; 42:751754.
  • 106
    Sanchez Carrillo CI, Ramirez Sanchez TJ, Zambrana Castaneda M & Selwyn BJ. Tests of a noninvasive instrument for measuring hemoglobin concentration. International Journal of Technology Assessment in Health Care 1989; 5:659667.
  • 107
    Nardone DA, Roth KM, Mazur DJ & McAfee JH. Uselfuness of physical examination in detecting the presence or absence of anemia. Archives of Internal Medicine 1990; 150:201204.
  • 108
    Sdepanian VL, Silvestrini WS & De Morais MB. Diagnostic limitations of the physical examination in the identification of children with anemia. Revista Da Associacao Medica Brasileira. 1996; 42:169174.
  • 109
    Ekunwe EO. Predictive value of conjunctival pallor in the diagnosis of anaemia. West Africa Journal of Medicine 1997; 16:246250.
  • 110
    Sheth TN, Choudhry NK, Bowes M & Detsky AS. The relation of conjunctival pallor to the presence of anemia. Journal of General Internal Medicine. 1997; 12:102106.
  • 111
    Van Den Broek NR, Ntonya C, Mhango E & White SA. Diagnosing anaemia in pregnancy in rural clinics: assessing the potential of the Haemoglobin Colour Scale. Bulletin of the World Health Organization 1999; 77:1521.
  • 112
    Stoltzfus RJ, Edward-Raj A, Dreyfuss ML, Albonico M, Montresor AQ & Dhoj Thapa M et al., Clinical pallor is useful to detect severe anemia in populations where anemia is prevalent and severe. Journal of Nutrition 1999; 129:16751681.
  • 113
    Meda N, Dao Y, Toure B, Yameogo B, Cousens S & Graham W. Assessing severe maternal anemia and its consequences: the value of a simple examination of the coloration of palpebral conjunctiva. Sante 1999; 9:1217.
  • 114
    Pistorius LR, Funk M, Pattinson RC & Howarth GR. Screening for anemia in pregancy with copper sulfate densitometry. International Journal of Gynaecology and Obstetrics 1996; 52:3336.
  • 115
    Young PC, Hamill B, Wasserman RC & Dickerman JD. Evaluation of the capillary microhematocrit as a screening test for anemia in pediatric office practice. Pediatrics 1986; 78:206209.
  • 116
    Mustaring Trangana S & Daud D. Capillary microhematocrit measurement as a screening test for anemia in children. Paediatrica Indonesia 1990; 30:241247.
  • 117
    World Health Organization. Iron Supplementation During Pregnancy: Why Aren’t Women Complying? Document WHO/MCH/90.12. Geneva: World Health Organization, 1990.
  • 118 World Health Organization. 
    The hypertensive disorders of pregnancy. Technical Report Series, Vol. 758. Geneva: World Health Organization, 1987.
  • 119
    Steer PJ. The definition of pre-eclampsia. British Journal of Obstetrics and Gynaecology 1999; 106:753755.
  • 120
    Chappell L, Poulton L, Halligan A & Shennan AH. Lack of consistency in research papers over the definition of pre-eclampsia. British Journal of Obstetrics and Gynaecology 1999; 106:983985.
  • 121
    Duley L. Maternal Mortality and Eclampsia: An Assessment of Levels and Possible Interventions. Report prepared for the Safe Motherhood Research Programme of the World Health Organization. Oxford: National Perinatal Epidemiology Unit, Radcliffe Infirmary, 1990.
  • 122
    Saudan P, Brown MA, Buddle ML & Jones M. Does gestational hypertension become pre-eclampsia? British Journal of Obstetrics and Gynaecology 1998; 105:11771184.
  • 123
    Redman CWG. Eclampsia still kills. British Medical Journal 1988; 296:12091210.
  • 124
    North RA, Taylor RS & Schellenberg JC. Evaluation of a definition of pre-eclampsia. British Journal of Obstetrics and Gynaecology 1999; 106:767773.
  • 125
    World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. American Journal of Obstetrics and Gynecology 1988; 158:8083.
  • 126
    Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. British Journal of Obstetrics and Gynaecology 1992; 99:547553.
  • 127
    Wallenburg HCS. Detecting hypertensive disorders of pregnancy. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 382402.
  • 128
    Campbell DM, MacGillivray IM & Carr-Hill R. Pre-eclampsia in second pregnancy. British Journal of Obstetrics and Gynaecology 1985; 92:131140.
  • 129
    Macgillivray I. Pre-Eclampsia: The Hypertensive Disease of Pregnancy. London: Saunders, 1983.
  • 130
    Green J. Diet and the prevention of pre-eclampsia. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 281300.
  • 131
    Belizan JM & Villar J. The relationship between calcium intake and edema, proteinuria, and hypertension-gestosis: an hypothesis. American Journal of Clinical Nutrition 1980; 33:22022210.
  • 132
    Hamlin RHJ. The prevention of eclampsia and pre-eclampsia. Lancet 1952; 1:6468.
  • 133
    Belizan JM, Villar J & Repke J. The relationship between calcium intake and pregnancy-induced hypertension: up to date evidence. American Journal of Obstetrics and Gynecology 1988; 158:898902.
  • 134
    Villar J, Belizan JM & Fisher PJ. Epidemiologic observation on the relationship between calcium intake and eclampsia. International Journal of Gynaecology and Obstetrics 1993; 21:271278.
  • 135
    Douglas KA & Redman CWG. Eclampsia in the United Kingdom. British Medical Journal 1994; 309:13951400.
  • 136
    Hogberg U & Joelsson I. The decline in maternal mortality in Sweden, 1931–1980. Acta Obstetricia et Gynecologica Scandinavica 1985; 64:583592.
  • 137
    De Swiet M. Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. American Journal of Obstetrics and Gynecology 2000; 182:760766.
  • 138
    Mtimavalye LAR, Lisasi D & Ntuyabaliwe WK. Maternal mortality in Dar es Salaam, Tanzania, 1974–1977. East African Medical Journal, 1980; 57:111118.
  • 139
    Mungra A, Van Kanten RW, Kanhai HHH & Van Roosmalen J. Nationwide maternal mortality in Surinam. British Journal of Obstetrics and Gynaecology 1999; 106:5559.
  • 140
    Hall MH, Chng PK & MacGillivray I. Is routine antenatal care worth while? Lancet 1980; 2:7880.
  • 141
    Conde Agudelo A, Lede R & Belizan J . Evaluation of methods used in the prediction of hypertensive disorders of pregnancy. Obstetrical and Gynecological Survey 1994; 49:210222.
  • 142
    Millar JGB, Campbell SK, Albano JDM, Higgins BR & Clark AD. Early prediction of pre-eclampsia by measurement of kallicrein and creatinine on a random urine sample. British Journal of Obstetrics and Gynaecology 1996; 103:421426.
  • 143
    Kyle PM, Campbell S, Buckkley D, Kissane J, De Swiet M & Albano J et al., A comparison of the inactive urinary kallikrein ratio and the angiotensin sensitivity test for the prediction of pre-eclampsia. British Journal of Obstetrics and Gynaecology 1996; 103:981987.
  • 144
    Villar J, Repke J, Markush L, Calvert W & Roads G. The measuring of blood pressure during pregnancy. American Journal of Obstetrics and Gynecology 1989; 161:10191024.
  • 145
    Lindheimer MD, Roberts JM, Cunningham FG & Chesley L. Introduction, history, controversies and definitions. In: Chesley’s Hypertensive Disorders in Pregnancy, 2nd edn. Editors: Lindheimer MD, Roberts JM, Cunningham FG. Stamford, CT: Appleton and Lange, 1999; pp. 336.
  • 146
    World Health Organization. Detecting Pre-eclampsia: A Practical Guide. Using and Maintaining Blood Pressure Equipment. Document WHO/MSM/92.3. Geneva: World Health Organization, 1992.
  • 147
    Duggan PM & Miller J. Blood pressure measurement in pregnancy–a survey of methods used in teaching hospitals in South Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology 1998; 38:197199.
  • 148
    Wen SW, Kramer MS, Hoey J, Hanley JA & Usher RH. Terminal digit preference, random error, and bias in routine clinical measurement of blood pressure. Journal of Clinical Epidemiology 1993; 15:122125.
  • 149
    Cleary R, Beard RW, Coles J, Devlin HB, Hopkins A & Roberts S et al., The quality of routinely collected maternity data. British Journal of Obstetrics and Gynaecology 1994; 101:10421047.
  • 150
    Wingfield D. Observational precision in general practice data: a technique for analysis and audit. IMA Journal of Mathematics Applied in Medicine and Biology 1995; 12:275281.
  • 151
    Hessel PA. Terminal digit preference in blood pressure measurements: effects on epidemiological associations. International Journal of Epidemiology 1986; 15:122125.
  • 152
    Bailey RH, Knaus VL & Bauer JH. Aneroid sphygmo-manometers: an assessment of accuracy at a University hospital and clinics. Archives of Internal Medicine 1991; 151:14091412.
  • 153
    De Swiet M & Shennan A. Blood pressure measurement during pregnancy. British Journal of Obstetrics and Gynaecology 1996; 103:862863.
  • 154
    National High Blood Pressure Education Program Working Group. Report on high blood pressure in pregnancy. American Journal of Obstetrics and Gynecology 1990; 163:16911712.
  • 155
    Wichman K & Ryden G. Blood pressure and renal function during normal pregnancy. Acta Obstetricia et Gynecologica Scandinavica 1986; 65:561566.
  • 156
    Lopez MC, Belizan JM, Villar J & Bergel E. The measurement of diastolic blood pressure during pregnancy: which Korotkoff phase should be used? American Journal of Obstetrics and Gynecology 1994; 170:574578.
  • 157
    Shennan AH, Kissane J & De Swiet M. Validation of Spacelabs 90207 ambulatory blood pressure monitor for use in pregnancy. British Journal of Obstetrics and Gynaecology 1993; 100:904908.
  • 158
    Franx A, Van Der Post JAM, Elfering IM, Veerman DP, Merkus HM & Boer K et al., Validation of automated blood pressure recording in pregnancy. British Journal of Obstetrics and Gynaecology 1994; 101:6669.
  • 159
    Brown MA, Robinson A & Buddle ML. Accuracy of automated blood pressure recorders in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1998; 38:262265.
  • 160
    Marx GF, Schwalbe SS & Cho E. Automated blood pressure measurements in labouring women: are they reliable? American Journal of Obstetrics and Gynecology 1993; 168:796798.
  • 161
    Gupta M, Shennan AH, Halligan A, Taylor DJ & De Swiet M. Accuracy of oscillometric blood pressure monitoring in pregnancy and pre-eclampsia. British Journal of Obstetrics and Gynaecology 1997; 104:350355.
  • 162
    Halligan AWF, Bell SC & Taylor DJ. Dipstick proteinuria: caveat emptor. British Journal of Obstetrics and Gynaecology 1999; 106:11131115.
  • 163
    Bell SC, Halligan AW, Martin A, Ashmore J, Shennan AH & Lamber PC et al., The role of observer error in antenatal dipstick proteinuria analysis. British Journal of Obstetrics and Gynaecology 1999; 106:11771180.
  • 164
    Kuo VS, Koumantakis G & Gallery ED. Proteinuria and its assessment in normal and hypertensive pregnancy. American Journal of Obstetrics and Gynecology 1992; 167:723728.
  • 165
    Meyer NL, Mercer BM, Friedman SA & Sibai BM. Urinary dipstick protein: a poor predictor of absent or severe proteinuria. American Journal of Obstetrics and Gynecology 1994; 170:137141.
  • 166
    Brown MA & Buddle ML. Inadequacy of dipstick proteinuria in hypertensive pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 1995; 35:366369.
  • 167
    Golding J, Shenton T & Macgillivray I. Could oedema and proteinuria in pregnancy be used to screen for high risk? Paediatric and Perinatal Epidemiology 1988; 2:2542.
  • 168
    Dexter L & Weiss S. Preeclampsia and Eclamptic Toxemia in Pregnancy. Boston, MA: Little, Brown, 1941; p. 22.
  • 169
    Sibai BM. Pitfalls in diagnosis and management of preeclampsia. American Journal of Obstetrics and Gynecology 1988; 159:15.
  • 170
    Golding J & Shenton T. Low birth-weight and pre-term delivery in South-East Asia. The WHO international collaborative study of hypertensive disorders of pregnancy. Social Science and Medicine 1990; 30:497502.
  • 171
    Atallah AN, Hofmeyr GJ & Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders of and related problems (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 172
    Levine RJ, Hauth JC, Curet LB, Sibai BM, Catalano PM & Morris CD et al., Trial of calcium to prevent preeclampsia. New England Journal of Medicine 1997; 337:6976.
  • 173
    Belizan JM, Villar J, Bergel E, Del Pino A, Di Fulvio S & Galliano SV. Long term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow-up of a randomised controlled trial. British Medical Journal 1997; 315:281285.
  • 174
    Duley L. Prophylactic fish oil in pregnancy. In: Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Editors: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP. London: BMJ Publishing Group, 1995[updated 24 February 1995].
  • 175
    Bulstra-Ramakers MTEW, Huisjes HJ & Visser GHA. The effects of 3g eicosapentanoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. British Journal of Obstetrics and Gynaecology 1995; 102:123126.
  • 176
    Salvig JD, Olsen SF & Secher NJ. Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. British Journal of Obstetrics and Gynaecology 1996; 103:529533.
  • 177
    Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ & Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. British Journal of Obstetrics and Gynaecology 2000; 107:382395.
  • 178
    Collins R. Antiplatelet agents for IUGR and pre-eclampsia. In: Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Editors: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP. London: BMJ Publishing Group, 1995[updated 24 February 1995].
  • 179
    ECPPA.(Estudo Colaborativo para Prevencao da Pre-eclampsia com Aspirina): randomised trial of low dose aspirin for the prevention of maternal and fetal complica-tions in high risk pregnant women. British Journal of Obstetrics and Gynaecology 1996; 103:3947.
  • 180
    Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M & Thom E et al. Low-dose aspirin to prevent preeclampsia in women at high risk. New England Journal of Medicine 1998; 338:701705.
  • 181
    Golding J, on behalf of The Jamaica Low Dose Aspirin Study Group. A randomised trial of low dose aspirin for primiparae in pregnancy. British Journal of Obstetrics and Gynaecology 1998; 105:293299.
  • 182
    Rotchell YE, Cruickshank JK, Phillips Gay M, Griffiths J, Stewart A & Farrell B et al. Barbados low dose aspirin study in pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications. British Journal of Obstetrics and Gynaecology 1998; 105:286292.
  • 183
    Knight M, Duley L, Henderson-Smart DJ & King JF. Antiplatelet agents for preventing and treating pre-eclampsia (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 184
    Spätling L & Spätling G. Magnesium supplementation in pregnancy: a double-blind study. British Journal of Obstetrics and Gynaecology 1988; 95:120125.
  • 185
    Sibai BM, Villar MA & Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 1989; 161:115119.
  • 186
    Gülmezoglu M, Hofmeyr GJ & Oosthuisen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. British Journal of Obstetrics and Gynaecology 1997; 104:689696.
  • 187
    Chappell LC, Seed PT, Briley AL, Kelly FJ, Hunt BJ & Parmar K et al., Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomised trial. Lancet 1999; 354:810816.
  • 188
    Goldenberg RL, Cliver SP, Bronstein J, Cutter GR, Andrews WW & Mennemeyer ST. Bed rest in pregnancy. Obstetrics and Gynecology 1994; 84:131136.
  • 189
    Duley L. Strict bed rest for proteinuric hypertension in pregnancy. In: Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Editors: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP. London: BMJ Publishing Group, 1995[updated 24 February 1995].
  • 190
    Duley L. Hospitalisation for non-proteinuric pregnancy hypertension. In: Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Editors: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP. London: BMJ Publishing Group, 1995[updated 24 February 1995].
  • 191
    Allen A, Glasziou P & Del Mar C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 1999; 354:12291233.
  • 192
    Magee LA, Ornstein MP & Von Dadelszen P. Management of hypertension in pregnancy. British Medical Journal 1999; 318:13321336.
  • 193
    Butters L, Kennedy S & Rubin PC. Atenolol in essential hypertension during pregnancy. British Medical Journal 1990; 301:587589.
  • 194
    Collins R & Duley L. Any antihypertensive therapy for pregnancy hypertension. In: Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Editors: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP. London: BMJ Publishing Group, 1995[updated 24 February 1995].
  • 195
    Von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G & Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355:8792.
  • 196
    Odendaal HJ, Pattinson RC, Barn R, Grove D & Kotze TJ. Aggressive or expectant management for patients with severe preeclampsia between 28 and 34 weeks’ gestation: a randomized controlled trial. Obstetrics and Gynecology 1990; 76:10701075.
  • 197
    Sibai BM, Mercer BM, Schiff E & Friedman SA. Aggressive versus expectant management of severe pre-eclampsia at 28–34 weeks’ gestation: a randomized controlled trial. American Journal of Obstetrics and Gynecology 1994; 171:818822.
  • 198
    Duley L & Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 199
    Belfort M, Anthony J & Saade G, Nimodipine Study Group. Interim report of the nimodipine vs. magnesium sulfate for seizure prophylaxis in severe preeclampsia study: an international, randomized controlled trial. American Journal of Obstetrics and Gynecology 1998; 178:7.
  • 200
    Duley L, Williams J & Henderson Smart DJ. Plasma volume expansion for treatment of women with pre-eclampsia. In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 201
    The Eclampsia Trial Collaborative Group. Which anti-convulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345:14551463.
  • 202
    Duley L & Henderson-Smart DJ. Magnesium sulphate versus diazepam for eclampsia (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 203
    Duley L & Henderson-Smart DJ. Magnesium sulphate versus phenytoin for eclampsia (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 204
    Duley L, Gulmezoglu AM & Henderson-Smart DJ. Anticonvulsants for pre-eclampsia (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 205
    Duley L & Neilson JP. Magnesium sulphate and pre-eclampsia. British Medical Journal 1999; 319:34.
  • 206
    World Health Organization.  The Prevention and Treatment of Obstetric Fistulae. Report of a Technical Working Group, Geneva, 17–21 April 1989. Document WHO/FHE/89.5. Geneva: World Health Organization, 1989.
  • 207
    Harrison K, Fleming AF, Briggs ND & Rossiter CE. Growth during pregnancy in Nigerian teenage primigravidae. British Journal of Obstetrics and Gynaecology 1985; 92(Suppl. 5):3239.
  • 208
    Scholl TO, Hediger ML & Ances IG. Growth during early teenage pregnancy. (letter). Lancet 1988; ii:738738.
  • 209
    Rush D. Effects of changes in protein and calorie intake during pregnancy on the growth of the human fetus. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp 255279.
  • 210
    Garner P, Kramer MS & Chalmers I. Might efforts to increase birthweight in undernourished do more harm than good? Lancet 1992; 340:10211023.
  • 211
    Merchant K, Villar J & Kestler E. Maternal height and newborn size relative to risk of intrapartum caesarean delivery and perinatal distress. Submitted.
  • 212
    Kasongo Project Team. Antenatal screening for fetopelvic dystocias. A cost-effectiveness approach to the choice of simple indicators for use by auxiliary personnel. Journal of Tropical Medicine and Hygiene 1984; 87:173183.
  • 213
    Lennox CE. Assessment of obstetric high risk factors in a developing country. Tropical Doctor 1984; 14:125129.
  • 214
    Hofmeyr GJ. Suspected fetopelvic disproportion. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 493498.
  • 215
    Baird D. Social factors in obstetrics. Lancet 1949; i:1079.
  • 216
    Moller B & Lindmark G. Short stature: an obstetric risk factor? A comparison of two villages in Tanzania. Acta Obstetricia et Gynecologica Scandinavica 1997; 76:394397.
  • 217
    WHO. Maternal Anthropometry and Pregnancy Outcomes. A WHO Collaborative Study. Bulletin of the World Health Organization 1995; 73:3234.
  • 218
    Sirur Project. Risk Approach and Intervention Strategy in MCH Care: Project Report (1981–1984). WHO/MCH Report. Geneva: World Health Organization, 1985.
  • 219
    Bauer O, Kingu R, Laussen T & Mbwana K. Pelvic assessment and cephalo-pelvic disproportion in Central Tanzania. International Journal of Gynaecology and Obstetrics 1988; 27:323325.
  • 220
    Pattinson RC. Pelvimetry for fetal cephalic presentations at term (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 221
    Gardosi J & Francis A. Controlled trial of fundal height measurement plotted on customised antenatal growth charts. British Journal of Obstetrics and Gynaecology 1999; 106:309317.
  • 222
    Grover V, Usha R, Kalra S & Sachdeva S. Altered fetal growth: antenatal diagnosis by symphysis-fundal height in India and comparison with western charts. International Journal of Gynaecology and Obstetrics 1991; 35:231234.
  • 223
    Dare FO, Ademowore AS, Ifaturoti OO & Nganwuchu A. The value of the sympysio–fundal height/abdominal girth measurements in predicting fetal weight. International Journal of Gynaecology and Obstetrics 1990; 31:243248.
  • 224
    Stock A, Ming WW, Rogers M & Chang AM. Prediction of caesarean section from ultrasound and clinical assessment of fetal size. Australian and New Zealand Journal of Obstetrics and Gynaecology 1994; 34:393398.
  • 225
    Persson B, Stangenberg M, Lunell NO, Brodin U, Holmberg NG & Vaclavinkova V. Prediction of size of infants at birth by measurement of symphysis fundus height. British Journal of Obstetrics and Gynaecology 1986; 93:206211.
  • 226
    Lindhard A, Nielsen PV, Mouritsen LA, Zachariassen A, Sorensen HU & Roseno H. The implications of introducing the symphyseal–fundal height-measurement. A prospective randomized controllled trial. British Journal of Obstetrics and Gynaecology 1990; 97:675680.
  • 227
    Neilson JP. Symphysis-fundal height measurement in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 228
    Hofmeyr GJ. External cephalic version for breech presentation before term (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 229
    Hofmeyr GJ & Kulier R. External cephalic version for breech presentation at term (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 230
    Buekens P, Tsui A, Kotelchuck M & Degraft-Johnson J. Tetanus immunization and prenatal care in developing countries. International Journal of Gynaecology and Obstetrics 1995; 48:9194.
  • 231
    Tan BP & Hannah ME. Oxytocin for prelabour rupture of membranes at or near term (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 232
    Tan BP & Hannah ME. Prostaglandin for prelabour rupture of membranes at or near term (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 233
    Tan BP & Hannah ME. Prostaglandin versus oxytocin for prelabour rupture of membranes at or near term (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 234
    Kenyon S & Boulvain M. Antibiotics for preterm premature rupture of membranes (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 235
    Kenyon S. ORACLE Trial. Personal Communication.
  • 236
    Crowley P. Prophylactic corticosteroids for preterm delivery (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 237
    Wang E & Smaill F. Infection in pregnancy. In: Effective Care in Pregnancy and Childbirth. Editors: Chalmers I, Enkin M, Keirse MJNC. Oxford: Oxford University Press, 1989; pp. 534564.
  • 238
    Brocklehurst P, Hannah M & Mcdonald H. Interventions for treating bacterial vaginosis in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 239
    Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thom EA & Ernest JM et al., Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. New England Journal of Medicine 2000; 342:534540.
  • 240
    Friedmann PS & Wright DJM. Observations on syphilis in Addis Ababa. 2. Prevalence and natural history. British Journal of Venereal Diseases 1977; 53:276280.
  • 241
    Osoba AO. Sexually transmitted diseases in tropical Africa. British Journal of Venereal Diseases 1981; 57:8994.
  • 242
    Ursi JP, Van Dyck E, Van Houtte C, Piot P, Colaert J & Dlamini M et al. Syphilis in Swaziland. British Journal of Venereal Diseases 1981; 57:9599.
  • 243
    Schulz KF, Schulte I & Berman S. Reproductive Tract Infections: Impact on Pregnancy Outcome and Child Survival. Atlanta, GA: Centers for Disease Control, 1991.
  • 244
    Isenberg SJ, Apt L & Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. New England Journal of Medicine 1995; 332:562566.
  • 245
    Brocklehurst P. Interventions for treating gonorrhoea in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 246
    Witkin SS, Inglis SR & Polaneczky M. Detection of Chlamidial trachomatis and Trichomonas vaginalis during pregnancy by introital sampling. American Journal of Obstetrics and Gynecology 1996; 174:409.
  • 247
    Chatterjee M & Humphrey A. Polymerase chain reaction (PCR) technology for diagnosis of Chlamydia trachomatis during pregnancy in urine and cervical swabs. American Journal of Obstetrics and Gynecology 1996; 174:410.
  • 248
    Brocklehurst P & Rooney G. Interventions for treating genital chlamydia trachomatis infection in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 249
    World Health Organization. Challenges in Reproductive Health Research. Biennial Report 1992–1993. Editors: Khanna J, Van Look PFA, Griffin PD. Geneva: World Health Organization, 1994.
  • 250
    Gibbs RS, Romero R, Hillier SL, Eschenbach DA & Sweet RL. A review of premature birth and subclinical infection. American Journal of Obstetrics and Gynecology 1992; 166: 15151528.
  • 251
    Gülmezoglu AM. Interventions for trichomoniasis in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 252
    World Health Organization.  HIV in Pregnancy: A Review. WHO7CHS7RHR799.15/UNAIDS/99.35E. Geneva: World Health Organization, 1999.
  • 253
    UNAIDS. AIDS Epidemic Update: December 1998. Geneva: Joint United Nations Programme on HIV/AIDS, 1998.
  • 254
    Ryder RW & Temmerman M. The effects of HIV-1 infection during pregnancy and the perinatal period on maternal and child health in Africa. AIDS 1991; 5(Suppl. 1):S75S85.
  • 255
    Johnstone FD. Pregnancy outcome and pregnancy management in HIV-infected women. In: HIV Infection in Women. Editors: Johnson MA, Johnstone FD. Edinburgh: Churchill Livingstone, 1993; pp. 187198.
  • 256
    Temmerman M. Human immunodeficiency virus and women. Journal of Obstetrics and Gynecology 1994; 14(Suppl. 2):S70S75.
  • 257
    Bakas C, Zarou DM & Decaprariis PJ. First-trimester spontaneous abortions and the incidence of human immunodeficiency virus seropositivity. Journal of Reproductive Medicine 1996; 41:1518.
  • 258
    Johnstone FD. HIV and pregnancy. British Journal of Obstetrics and Gynaecology 1996; 103:11841190.
  • 259
    Brocklehurst P & French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-anlysis. British Journal of Obstetrics and Gynaecology 1998; 105:839848.
  • 260
    Newell ML, Gray G & Bryson YJ. Prevention of mother to child transmission of HIV-1 transmission. AIDS 1997; 11(Suppl. A):S165S172.
  • 261
    Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results from 13 perinatal studies. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995; 8:506510.
  • 262
    Brocklehurst P. Interventions aimed at decreasing the risk of mother-to-child transmission of HIV infection (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 263
    Saba J. Identification of HIV infection in pregnancy: another era. Acta Paediatrica 1997; 421:6566.
  • 264
    Minkoff H & Willoughby A. The future of prenatal HIV testing. Acta Paediatrica 1997; 42:7277.
  • 265
    Millar LK & Cox SM. Urinary tract infections complicating pregnancy. Infectious Disease Clinics of North America 1997; 11:1326.
  • 266
    Patterson TF & Andriole VT. Detection, significance and therapy of bacteriuria in pregnancy. Infectious Disease Clinics of North America 1997; 11:593608.
  • 267
    Kincaid-Smith P, Bullen M, Mills J, Fussell U & Huston N. The reliability of screening tests for bacteriuria in pregnancy. Lancet 1964; i:6162.
  • 268
    Campbell-Brown M, McFayden IR, Seal DV & Stephenson ML. Is screening for bacteriuria in pregnancy worthwhile? British Medical Journal 1987; 294:15791582.
  • 269
    Dempsey C, Harrison RFF, Moloney A, Darling M & Walshe J. Characteristics of bacteriuria in a homogeneous maternity hospital population. European Journal of Obstetrics, Gynecology and Reproductive Biology 1992; 44:189193.
  • 270
    Stenqvist K, Dahlen-Nilsson I, Lidin-Janson G, Lincoln K, Oden A & Rignell S et al., Bacteriuria in pregnancy. Frequency and risk of acquisition. American Journal of Epidemiology 1989; 129:372379.
  • 271
    Lawson DH & Millier AWF. Screening for bacteriuria in pregnancy. Lancet 1971; i:911.
  • 272
    De La Rosa M, Rojas A, Garcia V, Herruzo A & Moreno I. Asymptomatic bacteriuria and piuria during pregnancy. Enfermedades Infecciosas y Microbiologicas Clinicas 1994; 12: 7981.
  • 273
    Versi E, Chia P, Griffiths DJ & Harlow BL. Bacteriuria in pregnancy: a comparison of Bangladeshi and Caucasian women. International Urogynecology Journal and Pelvic Floor Dysfunction 1997; 8:812.
  • 274
    Andrews W, Cox S & Gilstrap LC. Urinary tract infections in pregnancy. International Urogynecology Journal and Pelvic Floor Dysfunction 1990; 1:155163.
  • 275
    Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 276
    Villar J, Lydon-Rochelle MT & Gulmezoglu AM. Duration of treatment for asymptomatic bacteriuria during pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software, 2000.
  • 277
    Joseph KS, Brahmadathan KN, Abraham S & Joseph A. Detecting bacteriuria in a primary maternal and child health care programme. British Medical Journal 1988; 296:906907.
  • 278
    Abalos EJ. Review of two rapid screening tests for asymptomatic bacteriuria during pregnancy. Eighth Post-Graduate Course for Training in Reproductive Medicine and Reproductive Biology, Geneva, Switzerland. http://matweb.hcuge.ch/matweb/endo/pgc_network/abalos/inndex/htm, 1998.
  • 279
    World Health Organization.  International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. Geneva: World Health Organization, 1992.
  • 280
    Graham WJ & Campbell OMR. Measuring maternal health: defining the issues. Maternal and Child Epidemiology Unit Publication, No. 1. London: London School of Hygiene and Tropical Medicine, 1990.
  • 281
    World Health Organization.  Measuring Reproductive Morbidity. Document WHO/MCH/90.4. Geneva: World Health Organization, 1990.
  • 282
    Feachem RGA, Kjellstrom T, Murray CJL, Over M & Phillips MA (Editors). The Health of Adults in the Developing World. Washington, DC: The World Bank, 1991.
  • 283
    Hayes R, Mertens T, Locket G & Rodrigues LC. Measuring Cause Specific Adult Mortality in Developing Countries. Working Paper. Washington, DC: The World Bank, 1989.
  • 284
    Sobelavsky O. Prevalence of markers of hepatitis B infection in various countries. A WHO collaborative study. Bulletin of the World Health Organization 1980; 58:621628.
  • 285
    Simms J & Duff P. Viral hepatitis in pregnancy. Seminars in Perinatology 1993; 17:384393.
  • 286
    Tsega E, Krawcynski K, Hansson BG & Nordenfelt E. Hepatitis E virus in pregnancy in Ethiopia. Ethiopian Medical Journal 1993; 31:173181.
  • 287
    Rodrigues LC & Smith PG. Tuberculosis in developing countries and methods for its control. Transactions of the Royal Society of Tropical Medicine and Hygiene 1990; 84: 739744.
  • 288
    Ahmed Y, Mwaba P, Chintu C, Grange JM, Ustianowski A & Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. International Journal of Tuberculosis and Lung Disease 1999; 3:675680.